Package 82143-002-01

Brand: avzivi

Generic: bevacizumab-tnjn
NDC Package

Package Facts

Identity

Package NDC 82143-002-01
Digits Only 8214300201
Product NDC 82143-002
Product ID 82143-002_3fff12d3-d86b-14e4-e063-6294a90a122e
Description

1 VIAL in 1 CARTON (82143-002-01) / 16 mL in 1 VIAL

Marketing

Marketing Status
Marketed Since 2025-01-01
Brand avzivi
Generic bevacizumab-tnjn
Sample Package No

Linked Drug Pages (1)

Avzivi tnjn, Avzivi ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "3fff12d3-d86b-14e4-e063-6294a90a122e", "openfda": {"unii": ["2S9ZZM9Q9V"], "rxcui": ["2700735", "2700742", "2700744", "2700745"], "spl_set_id": ["a3976cf9-9edb-4ca2-9375-9bcd2e32f5b4"], "manufacturer_name": ["Bio-Thera Solutions, Ltd."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (82143-002-01)  / 16 mL in 1 VIAL", "package_ndc": "82143-002-01", "marketing_start_date": "20250101"}], "brand_name": "Avzivi", "product_id": "82143-002_3fff12d3-d86b-14e4-e063-6294a90a122e", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Vascular Endothelial Growth Factor Inhibitor [EPC]", "Vascular Endothelial Growth Factor Inhibitors [MoA]", "Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]"], "product_ndc": "82143-002", "generic_name": "bevacizumab-tnjn", "labeler_name": "Bio-Thera Solutions, Ltd.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Avzivi", "active_ingredients": [{"name": "BEVACIZUMAB-TNJN", "strength": "400 mg/16mL"}], "application_number": "BLA761198", "marketing_category": "BLA", "marketing_start_date": "20250101", "listing_expiration_date": "20261231"}